ArticleClinical lymphoma, myeloma & leukemia2025

Measurable Residual Disease Testing Following Nonintensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.

Julie E Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.